Farokhzad pointed to several large-scale deployments as evidence of platform adoption, including a 20,000-sample population study with Korea University and a 10,000-sample project in collaboration with Discovery Life Sciences. He said studies of that magnitude were not previously feasible with traditional mass spectrometry proteomics approaches, which he characterized as lacking the depth and scalability needed for standardized processing of tens of thousands of samples.Chief Executive Officer Omid Farokhza ...

Seer (NasdaqGS:SEER) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Company ParticipantsDavid Horn - President and CFOKelly Gura - Principal of Investor RelationsKyle Boucher - Vice President of Healthcare Equity ResearchOmid Farokhzad - Founder, Chairman, and CEOOperatorGood day, and welcome to the Seer fourth quarter 2025 earnings conference call. Today, all participants will be in a listen-only mode. Should you need assistance during today's call, please signal for a conference specialist by pressin ...

Seer (NasdaqGS:SEER) Q4 2025 Earnings call February 26, 2026 04:30 PM ET Speaker3Good day, and welcome to the Seer 4th quarter 2025 earnings conference call. Today, all participants will be in a listen-only mode. Should you need assistance during today's call, please signal for a conference specialist by pressing the star key followed by 0. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star, then 1 on your telephone keypad. To withdraw your quest ...